心脈醫療(688016.SH)半年度淨利潤預增51.4%-55.55%
格隆匯7月19日丨心脈醫療(688016.SH)公佈,公司預計2021年半年度實現歸屬於母公司所有者的淨利潤為18250萬元到18750萬元,與上年同期(法定披露數據)相比,將增加6196.17萬元到6696.17萬元,同比增加51.40%到55.55%。
預計2021年半年度歸屬於母公司所有者的扣除非經常性損益的淨利潤為17750萬元到18250萬元,與上年同期(法定披露數據)相比,將增加6808.18萬元到7308.18萬元,同比增加62.22%到66.79%。
報吿期內,公司銷售收入及淨利潤較2020年上半年度均取得較快增長,主要原因系2020年上半年度受新冠肺炎疫情的影響,醫療機構的手術開展受到較大限制,故2020年上半年度公司業務開展受到一定影響。2021年上半年隨着新冠疫情得到控制,醫院門診逐步恢復正常,同時公司繼續不斷加大市場開拓力度,近年獲批上市的Castor分支型主動脈覆膜支架及輸送系統、Minos腹主動脈覆膜支架及輸送系統、Reewarm PTX藥物球囊擴張導管等新產品均實現了快速增長,因此公司整體銷售收入較去年同期實現了較快增長,淨利潤同比亦有較大提高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.